<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Viral serological test is an efficient investigative means to determine the prevalence for SARS-CoV-2 infection among the population [
 <xref ref-type="bibr" rid="CR53">53</xref>]. COVID-19 infection stimulates IgG antibodies against N protein that can be noticed in serum as early as day 4 after the onset of disease, and in most patients seroconversion take place by day 14 [
 <xref ref-type="bibr" rid="CR24">24</xref>]. IgG illustrated higher positive rate and titer variance than that of IgM in COVID-19 [
 <xref ref-type="bibr" rid="CR53">53</xref>]. Detection of IgM and IgG against SARS-CoV-2 is a fast and easy monitoring method [
 <xref ref-type="bibr" rid="CR54">54</xref>]. Combined examination of the IgM-IgG proved better efficacy and sensitivity compared to a single antibody [
 <xref ref-type="bibr" rid="CR55">55</xref>].
</p>
